GlassScriptPhysician profile
Ashley Harnden
NPI 1144531500
$6,809.29
in general payments reported to CMS, 2019-2025
31 companies · $1,460 in 2025
The $1,460 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2021: $94.44 · 2022: $472 · 2023: $920 · 2024: $3,663 · 2025: $1,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,992 · Education: $1,458 · Travel and Lodging: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,992.36 |
| Education | $1,457.87 |
| Travel and Lodging | $593.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,739.91 | 2023-2024 | Da Vinci Surgical System |
| Organogenesis INC. | $1,584.71 | 2022-2025 | Puraply Wound Matrix, Puraply, Apligraf |
| Kerecis Limited | $672.95 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Convatec INC. | $204.44 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $192.40 | 2021-2022 | |
| Smith+Nephew, INC. | $191.49 | 2019-2025 | Grafix Pl, Oasis |
| Endologix LLC | $150.00 | 2024 | Torus Stent Graft System, Endocross Device |
| Bard Peripheral Vascular, INC. | $133.01 | 2022-2024 | Lutonix Drug Coated Balloon |
| Davol INC. | $100.00 | 2023 | Phasix Mesh |
| Boston Scientific Corporation | $87.12 | 2023-2025 | General - Pain Management |
| Acera Surgical, INC. | $75.21 | 2024-2025 | Restrata Wound Matrix |
| Ethicon US, LLC | $75.02 | 2019 | |
| Solventum Corporation | $72.52 | 2024-2025 | Activ.A.C., 3m Cavilon |
| Hartmann USA, INC. | $58.21 | 2022-2025 | Zetuvit Plus, Zetuvit Plus 10x10 P10 |
| Allergan, INC. | $50.87 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cashflow Solutions, LLC | $49.62 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Conmed Corporation | $44.44 | 2023 | Airseal |
| Urgo Medical North America, LLC | $34.77 | 2025 | Urgoclean Ag |
| Next Science LLC | $33.71 | 2023 | Surgx, Xperience, Blastx |
| Avita Medical Americas, LLC | $29.65 | 2024 | |
| Integra Lifesciences Corporation | $28.55 | 2022 | |
| Abbvie INC. | $28.43 | 2022 | |
| Heron Therapeutics, INC. | $27.08 | 2022 | |
| Bsn Medical INC | $25.76 | 2025 | |
| Tela Bio, INC. | $25.16 | 2024 | Ovitex 2s |
| Innocoll Pharmaceuticals Limited | $21.22 | 2022 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Tactile Systems Technology INC | $19.83 | 2025 | Nimbl, Flexitouch Plus |
| Acell, INC. | $16.27 | 2019 | |
| Shire North American Group INC | $11.22 | 2019 | |
| Lifenet Health | $5.72 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Harnden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.